Clémentine Nordon

1.1k total citations · 1 hit paper
66 papers, 679 citations indexed

About

Clémentine Nordon is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Clémentine Nordon has authored 66 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 13 papers in Psychiatry and Mental health and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Clémentine Nordon's work include Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Schizophrenia research and treatment (9 papers). Clémentine Nordon is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Schizophrenia research and treatment (9 papers). Clémentine Nordon collaborates with scholars based in United Kingdom, France and United States. Clémentine Nordon's co-authors include Kirsty Rhodes, Bruno Falissard, Lucien Abenhaim, Frédéric Rouillon, Hélène Karcher, Michel Rossignol, Mikkel Zöllner Ankarfeldt, Hélène Chevrou‐Séverac, Rolf H. H. Groenwold and Adeline Abbé and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Clémentine Nordon

53 papers receiving 668 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease

2024 34 citations Nathaniel M. Hawkins, Clémentine Nordon et al. Heart profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clémentine Nordon United Kingdom	16	254	110	104	83	77	66	679
Shayan Shirazian United States	12	120 0.5×	83 0.8×	76 0.7×	70 0.8×	54 0.7×	26	740
Carles Forné Spain	13	134 0.5×	82 0.7×	76 0.7×	34 0.4×	29 0.4×	41	712
Josep Darbà Spain	16	140 0.6×	129 1.2×	160 1.5×	31 0.4×	47 0.6×	109	906
Kristina Chen United States	18	149 0.6×	65 0.6×	108 1.0×	68 0.8×	15 0.2×	52	726
M. E. Edmunds United Kingdom	13	127 0.5×	153 1.4×	37 0.4×	29 0.3×	83 1.1×	34	783
Jacek Polański Poland	16	191 0.8×	170 1.5×	43 0.4×	39 0.5×	102 1.3×	47	906
Yolanda Bravo Vergel United Kingdom	11	149 0.6×	28 0.3×	80 0.8×	27 0.3×	66 0.9×	14	799
Willem M. van der Wal Netherlands	12	158 0.6×	161 1.5×	30 0.3×	23 0.3×	50 0.6×	15	751
Gerardo Machnicki United States	15	55 0.2×	35 0.3×	188 1.8×	43 0.5×	47 0.6×	42	790
Kathleen A. Foley United States	15	140 0.6×	68 0.6×	174 1.7×	15 0.2×	44 0.6×	33	969

Countries citing papers authored by Clémentine Nordon

Since Specialization

Citations

This map shows the geographic impact of Clémentine Nordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clémentine Nordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clémentine Nordon more than expected).

Fields of papers citing papers by Clémentine Nordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clémentine Nordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clémentine Nordon. The network helps show where Clémentine Nordon may publish in the future.

Co-authorship network of co-authors of Clémentine Nordon

This figure shows the co-authorship network connecting the top 25 collaborators of Clémentine Nordon. A scholar is included among the top collaborators of Clémentine Nordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clémentine Nordon. Clémentine Nordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hawkins, Nathaniel M., Clémentine Nordon, Manisha Talukdar, et al.. (2025). Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV study. ERJ Open Research. 11(6). 1212–2024.

Zysman, M., et al.. (2025). Risk of cardiovascular events according to the severity of an exacerbation of chronic obstructive pulmonary disease. European Journal of Preventive Cardiology. 32(15). 1436–1444. 2 indexed citations

Daniels, Kimberly, Stephan Lanes, Michael Pollack, et al.. (2024). Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. International Journal of COPD. Volume 19. 225–241. 19 indexed citations

Hawkins, Nathaniel M., Clémentine Nordon, Kirsty Rhodes, et al.. (2024). Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease. Heart. 110(10). 702–709. 34 indexed citations breakdown →

Bell, John, Clémentine Nordon, Constantinos Kallis, et al.. (2024). EXACOS CARBON: Describing the Greenhouse Gas Emissions of Healthcare Resource Utilization by Frequency and Severity of COPD Exacerbation in England. A2113–A2113.

Nordon, Clémentine, Sami O. Simons, Jonathan Marshall, et al.. (2024). The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies. ERJ Open Research. 11(3). 1091–2024. 4 indexed citations

Nordon, Clémentine, Malin Fagerås, Hana Müllerová, et al.. (2024). Exacerbation and mortality in COPD patients on triple inhaler and at high exacerbation risk. Epidemiology. PA1287–PA1287.

Janssens, Wim, Clémentine Nordon, George Bell, et al.. (2024). Characteristics of exacerbating COPD patients with productive cough and on inhaled triple therapy, by smoking status: a real-world multi-country study. Epidemiology. PA1288–PA1288. 1 indexed citations

Soyza, Anthony De, et al.. (2024). Perception of COPD control by physicians managing symptomatic exacerbating patients receiving inhaled triple therapy: a real-world multi-country 2022 survey. Epidemiology. PA1289–PA1289. 1 indexed citations

10.

Swart, Karin M. A., Fernie J. A. Penning‐van Beest, Camilla Bengtsson, et al.. (2023). Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands. Respiratory Research. 24(1). 293–293. 24 indexed citations

11.

Nordon, Clémentine, Kirsty Rhodes, Jennifer K Quint, et al.. (2023). EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies. BMJ Open. 13(4). e070022–e070022. 16 indexed citations

12.

Müllerová, Hana, Jonathan Marshall, Enrico De Nigris, et al.. (2022). Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease. 16. 2673692975–2673692975. 40 indexed citations

13.

Turner, Andrew, Dianne Gove, Amanda Ly, et al.. (2020). Health Outcome Prioritization in Alzheimer’s Disease: Understanding the Ethical Landscape. Journal of Alzheimer s Disease. 77(1). 339–353. 4 indexed citations

14.

Nordon, Clémentine, Hélène Verdoux, Josep María Haro, et al.. (2017). The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs. Clinical Epidemiology. Volume 9. 689–698. 3 indexed citations

15.

Nordon, Clémentine, Mark Belger, Javier Jiménez, et al.. (2017). Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database. Schizophrenia Research. 193. 146–153. 7 indexed citations

16.

Nordon, Clémentine, Michel Aubier, Gabriel Thabut, et al.. (2016). The Burden of Severe Asthma in France. Value in Health. 19(7). A560–A561. 1 indexed citations

17.

Grimaldi‐Bensouda, Lamiae, Clémentine Nordon, Marc Michel, et al.. (2016). Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome. Haematologica. 101(9). 1039–1045. 58 indexed citations

18.

Carré, Arnaud, Massimiliano Orri, Mathieu Urbach, et al.. (2016). The real-life effectiveness of psychosocial therapies on social autonomy in schizophrenia patients: Results from a nationwide cohort study in France. Psychiatry Research. 247. 97–104. 6 indexed citations

19.

Karcher, Hélène, et al.. (2015). A Practical Guide To Adding Patient Heterogeneity Into Phase Iii Trials: Results from Imi Getreal Wp2. Value in Health. 18(7). A727–A727. 1 indexed citations

20.

Nordon, Clémentine, Karin Martin‐Latry, Philippe Latry, et al.. (2009). Risk of Death Related to Psychotropic Drug Use in Older People During the European 2003 Heatwave: A Population-Based Case–Control Study. American Journal of Geriatric Psychiatry. 17(12). 1059–1067. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact